Intelligo

Private limited company · Oslo

KLYV THERAPEUTICS AS

ActiveResearch and experimental development on natural sciences and engineering (72.100)

Founded
30 Aug 2023
Chief executive
Maria Vistnes
Business address
Gaustadalléen 21, 0349 Oslo

The life line 2023–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 2.2m.

  1. Chair took office§ 07
  2. Managing director took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 4 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

KLYV THERAPEUTICS AS is a private limited company in Oslo, founded in 2023, in the industry research and experimental development on natural sciences and engineering. The chief executive is Maria Vistnes, and the chair of the board is Renée Christine Amundsen. In 2025 the company had NOK 2.2m in operating revenue and a net profit of NOK −1.1m. The largest owner is SPRINGHEART HOLDING AS with 77.5%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 8 Oct 2026

  • Changed capital 121816 → 140328
  • New articles of association 1 Jul 2026
  • Endring av kapital
  • Endring av vedtektsdato

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

2 points

  • Note3 of 5 on the board are new in the last 12 months
  • OKEquity ratio 85.2%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 2.2m in 2025

Revenue

NOK 2.2m

+136.1% from 2024

20232025

Operating profit

NOK −1.1m

−759.9% from 2024

20232025

Net profit

NOK −1.1m

−962.2% from 2024

20232025

Equity

NOK 6.7m

+828.5% from 2024

20232025

Source: the Register of Company Accounts, read 4 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Operating costs 148%

Costs exceeded revenue: the operating result was NOK −1.1m.

Source: the Register of Company Accounts, read 4 Nov 2026

Finances

§ 05 Financial health

Equity ratio 85.2%

RevenueNOK 2.2m Operating margin−48.3% Equity ratio85.2% Revenue growth+136.1%
  • KLYV THERAPEUTICS AS, 2025
  • Industry median, assumed: NOK 1.5m · −4.4% · 48.9% · +3.0%

Equity NOK 6.7m85% of the assets (NOK 7.8m)

Source: the Register of Company Accounts, read 4 Nov 2026. The median is derived by Intelligo from 694 companies in 72.100 Research and experimental development on natural sciences and engineering, not stated by the source.

Finances

§ 06 Accounts

3 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue2,2079350
Operating profit−1,065161−0
Profit before tax−1,061158−0
Net profit−1,061123−0
Total assets7,81693494
Equity6,66271894
Liabilities1,1542170

Source: the Register of Company Accounts, read 4 Nov 2026 · All 3 years →

Management and ownership

§ 07 Officers

7 officers now

The board: 5 members

Source: the Brønnøysund Register Centre, read 23 Aug 2026 · All 7 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

3 valid powers of attorney

The board has 3 authorisations in force now: capital increase, until 18 May 2027; fullmakt konvertibelt lån, until 18 May 2027; acquisition of own shares, until 2 Dec 2026.

Source: authorisations from the announcements of the Register of Business Enterprises, read 1 Nov 2026

Management and ownership

§ 09 Owners

4 shareholders · largest 77.5%

OwnerShare
SPRINGHEART HOLDING AS
77.5%
TAILORMADE INVEST AS
19.8%
PRECO AS
1.4%
1 others1.2%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 30 Jul 2026 · All 4 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

21 connections

  • Person
  • Company

5 people link KLYV THERAPEUTICS AS to 16 other companies: Renée Christine Amundsen 5, Andreas Berg 3, Jan Fikkan 4, Maria Vistnes 2 and Beret Luise Sundet 2.

Source: the Brønnøysund Register Centre, read 23 Aug 2026 · Explore the network →

Events and registers

§ 13 Events

29 since 2023

Events per year

20232026

  • Notices25
  • Register changes4

Since 2023: 25 announcements and 4 register changes. Most happened in 2025 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 29 events →

Events and registers

§ 14 Notices

25, latest 7 Oct 2026

  • Kapital
  • Vedtektsdato
  • Erverv av egne aksjer-fullmakt

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 25 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 24 Oct 2023
  • VATRegistered
  • The Register of Business EnterprisesRegistered 24 Oct 2023
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Utvikle og investere i legemidler, legemiddelkandidater, hjelpemidler, verktøy og metoder for pasientbehandling og persontilpasset medisin.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 72.100

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

5 questions

  • Who is the chief executive of KLYV THERAPEUTICS AS?
    Maria Vistnes, since 2023. § 07
  • Who owns KLYV THERAPEUTICS AS?
    4 shareholders. The largest is SPRINGHEART HOLDING AS with 77.5%, TAILORMADE INVEST AS with 19.8% and PRECO AS with 1.4%. § 09
  • What was the revenue in 2025?
    NOK 2.2m in the company. § 06
  • Where is KLYV THERAPEUTICS AS based?
    Gaustadalléen 21, 0349 Oslo.
  • When was KLYV THERAPEUTICS AS founded?
    30 Aug 2023, registered in the Register of Business Enterprises 24 Oct 2023. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose